Gregory R. Bebernitz

Author

Novartis (United States)

Also Known As

G. Bebernitz, G. R. BEBERNITZ, G. R. Bebernitz, Gregory Bebernitz, Gregory R. Bebernitz

Publications

530

Citations

H-Index

Concepts

All Affiliations

Novartis (United States)Novartis (Switzerland)

About

Gregory R. Bebernitz is an author at Novartis (United States) specializing in pharmacology, medicine, and medicinal chemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	462
2	Biochemistry	5	5	347
3	Natural Sciences	4	4	277
4	Engineering	2	2	53
5	Health Sciences	2	2	153

Gregory R. Bebernitz

Publications

494

Citations

H-Index

Page 1

	Year	Citations
The Effect of 1,3-Diaryl-[1H]-pyrazole-4-acetamides on Glucose Utilization in ob/ob Mice Gregory R. Bebernitz, Greg Argentieri, Beverly Battle, Journal of Medicinal Chemistry Glucose TransportMetabolic SyndromeMedicinal ChemistryPharmacological StudyBiochemistry	2001	140
Investigation of Functionally Liver Selective Glucokinase Activators for the Treatment of Type 2 Diabetes Gregory R. Bebernitz, Valérie Beaulieu, Bethany A. Dale, Journal of Medicinal Chemistry Gk EnzymeGlycobiologyPharmaceutical ChemistrySulfonamide ChemotypeInsulin Signaling	2009	91
Total synthesis of (-)-tirandamycin A R. H. Schlessinger, Gregory R. Bebernitz, Peter Lin, Journal of the American Chemical Society Medicinal ChemistryBiosynthesisMolecular SciencesChemical MeasurementDonut Icon	1985	83
Anilides of (<i>R</i>)-Trifluoro-2-hydroxy-2-methylpropionic Acid as Inhibitors of Pyruvate Dehydrogenase Kinase Gregory R. Bebernitz, Thomas D. Aicher, James L. Stanton, Journal of Medicinal Chemistry Pharmaceutical ScienceOral BioavailabilityLactate LevelsChemical BiologyChemical Derivative	2000	60
(<i>R</i>)-3,3,3-Trifluoro-2-hydroxy-2-methylpropionamides Are Orally Active Inhibitors of Pyruvate Dehydrogenase Kinase Thomas D. Aicher, Robert C. Anderson, Gregory R. Bebernitz, Journal of Medicinal Chemistry Molecular PharmacologyMedicinal ChemistryMolecular SciencesBiochemistryMedicine	1999	43
Avoidance of the Ames test liability for aryl–amines via computation Patrick McCarren, Gregory R. Bebernitz, Peter Gedeck, Bioorganic & Medicinal Chemistry EngineeringAmes Test LiabilityMedicineOrganic ChemistryAnalytical Chemistry	2011	32
A versatile 3-acyltetramic acid reagent R. H. Schlessinger, Gregory R. Bebernitz The Journal of Organic Chemistry AltmetricsEngineeringInformationAltmetric Attention ScoreChemometrics	1985	21
Reduction in Glucose Levels in STZ Diabetic Rats by 4-(2,2-Dimethyl-1-oxopropyl)benzoic Acid: A Prodrug Approach for Targeting the Liver Gregory R. Bebernitz, Jeremy G. Dain, Rhonda Oetting Deems, Journal of Medicinal Chemistry Fatty Liver DiseaseOxidative StressMetabolic SyndromeBenzoic AcidFasting Hyperglycemia	2000	13
Hypoglycemic Prodrugs of 4-(2,2-Dimethyl-1-oxopropyl)benzoic Acid Thomas D. Aicher, Gregory R. Bebernitz, Philip Bell, Journal of Medicinal Chemistry	1998	11

Page 1